Inflammatory response during bacterial meningitis is unchanged in Fas- and Fas ligand-deficient mice

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages 78-82

  Paul, Robert ^a   Angele, Barbara ^a   Sporer, Bernd ^a   Pfister, Hans Walter ^a   Koedel, Uwe ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bacterial meningitis; Fas; FasL; Interleukin 1beta

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BLOOD VESSEL PERMEABILITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; HEALTH STATUS; HUMAN; INFLAMMATION; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; WILD TYPE;

ANIMALS; ANTIGENS, CD95; BRAIN; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HUMANS; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, MUTANT STRAINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042608293     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.04.004     Document Type: Article

References (13)

1. Duez C., Tomkinson A., Shultz L.D., Bratton D.L., Gelfand E.W. Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge. J. Allergy Clin. Immunol. 108:2001;547-556
2. Fecho K., Cohen P.L. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J. Leukoc. Biol. 64:1998;373-383
3. Green D.R., Ferguson T.A. The role of Fas ligand in immune privilege. Nat. Rev., Mol. Cell Biol. 2:2001;917-924
4. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2:2002;721-736
5. Koedel U., Winkler F., Angele B., Fontana A., Flavell R.A., Pfister H.W. Role of caspase-1 in experimental pneumococcal meningitis: evidence from pharmacologic caspase inhibition and caspase-1-deficient mice. Ann. Neurol. 51:2002;319-329
6. Lee S.J., Zhou T., Choi C., Wang Z., Benveniste E.N. Differential regulation and function of Fas expression on glial cells. J. Immunol. 164:2000;1277-1285
7. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:1996;429-440
8. Miwa K., Asano M., Horai R., Iwakura Y., Nagata S., Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 4:1998;1287-1292
9. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., Pfister H.W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44:1998;592-600
10. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788
11. Schneider T.J., Fischer G.M., Donohoe T.J., Colarusso T.P., Rothstein T.L. An novel gene encoding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J. Exp. Med. 189:1999;949-955
12. Shudo K., et al. The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity. Eur. J. Immunol. 31:2001;2504-2511
13. Zhonh X., Schneider T.J., Cabral D.S., Donohoe T.J., Rothstein T.L. An alternatively spliced long form of Fas apoptosis inhibitory molecule (FAIM) with tissue-specific expression in the brain. Mol. Immunol. 38:2001;65-72